JAMA Reports ‘Breakthrough’ in Early Diagnosis of Alzheimer’s
August 12, 2009
Comments
2 Responses to “JAMA Reports ‘Breakthrough’ in Early Diagnosis of Alzheimer’s”
Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.
This type of research is exactly why clinical studies are so important.
It is important for patients and families affected by diseases such as Alzheimer’s to consider participating in clinical studies. One such study is the ICARA Study (www.icarastudy.com), whose goal is to explore if an investigational drug, called Bapineuzumab, can help slow the progression of Alzheimer’s Disease. Clinical studies that test new treatments are the best chance we have for fighting this disease. Current therapies for Alzheimer’s treat the symptoms associated with it, not the disease itself.
[...] (ChattahBox) — A combination of proteins in the cerebrospinal fluid can reliably identify which patients with early symptoms of dementia will subsequently. Symptom Of Alzheimers [...]